16-30902207-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001330.5(CTF1):c.274G>A(p.Ala92Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000266 in 1,172,800 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001330.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTF1 | NM_001330.5 | c.274G>A | p.Ala92Thr | missense_variant | 3/3 | ENST00000279804.3 | NP_001321.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTF1 | ENST00000279804.3 | c.274G>A | p.Ala92Thr | missense_variant | 3/3 | 1 | NM_001330.5 | ENSP00000279804 | P3 | |
CTF1 | ENST00000395019.3 | c.271G>A | p.Ala91Thr | missense_variant | 3/3 | 1 | ENSP00000378465 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000583 AC: 87AN: 149168Hom.: 1 Cov.: 31
GnomAD4 exome AF: 0.000220 AC: 225AN: 1023520Hom.: 0 Cov.: 30 AF XY: 0.000242 AC XY: 117AN XY: 484080
GnomAD4 genome AF: 0.000583 AC: 87AN: 149280Hom.: 1 Cov.: 31 AF XY: 0.000755 AC XY: 55AN XY: 72858
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 06, 2012 | Variant classified as Uncertain Significance - Favor Benign. The Ala92Thr varian t in CTF1 has not been reported in the literature nor previously identified by o ur laboratory. This variant has been listed in dbSNP (rs2234933) without frequen cy information. Computational analyses (biochemical amino acid properties, conse rvation, AlignGVGD, PolyPhen2, and SIFT) suggest that this variant may not impac t the protein, though this information is not predictive enough to rule out path ogenicity. Additional information is needed to fully assess the clinical signifi cance of this variant. - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 16, 2022 | Variant summary: CTF1 c.274G>A (p.Ala92Thr) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00059 in 147944 control chromosomes in the gnomAD v3.1.2 database, including 1 homozygote. The observed variant frequency is approximately 38-fold of the estimated maximal expected allele frequency for a pathogenic variant in CTF1 causing Dilated Cardiomyopathy phenotype (1.6e-05), strongly suggesting that the variant is benign. c.274G>A has been reported in the literature in individuals affected with Dilated Cardiomyopathy (Erdmann_2000, Akinrinade_2015). These reports do not provide unequivocal conclusions about association of the variant with Dilated Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. A ClinVar submitter (evaluation after 2014) cites the variant as uncertain significance, while another ClinVar submitter (evaluation after 2014) cites it as benign. Based on the evidence outlined above, the variant was classified as benign. - |
Primary familial hypertrophic cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Blueprint Genetics | Mar 16, 2015 | - - |
Dilated Cardiomyopathy, Dominant Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 08, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at